SYNOPSIS: A retrospective, observational, single-center study found immunocompromised patients are at increased risk for neurologic sequelae from HSV meningitis and likely benefit from antiviral therapy. There is no benefit to antiviral therapy in immunocompetent individuals.
Article Limit Reached
You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.
- Award-winning Medical Content
- Latest Advances & Development in Medicine
- Unbiased Content